Alkem Laboratories Limited (ALKEM) — Announcement | 2 June 2026

StockFin.ai

Try Free

📢 Key Event
Alkem launches semaglutide in single-shot pre-filled syringes at INR350 starting price

💡 Investor Takeaway
This expands patient access to semaglutide with a lower-cost delivery option, potentially boosting market share in diabetes and obesity treatments.

Alkem Laboratories announced it is India's first to launch semaglutide in single-shot pre-filled syringes priced starting at INR350, expanding patient access to diabetes and obesity treatments. The company previously launched semaglutide pens in March 2026 and received DCGI approval for vials. This new delivery format aims to lower entry barriers and complements existing options, reflecting Alkem's focus on affordable, multi-format therapies for metabolic disorders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ALKEM ✨ Ask AI About This

About Alkem Laboratories Limited (ALKEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹65,593.36 Cr P/E: 27.7 ROE: 19.8% ROCE: 22.1%

View full ALKEM stock details →

📡 Get AI alerts when ALKEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ALKEM — Free

💡 Ask AI about this filing

"How does this announcement affect Alkem Laboratories Limited's outlook?" "What did Alkem Laboratories Limited announce on 2 June 2026?" "Is this positive or negative for ALKEM?"

Ask AI Free →

📊 More ALKEM filings

See all ALKEM filings →

🔥 Also filed on 2 June 2026

NH Narayana Hrudayalaya Ltd. Financial Results USHAMART Usha Martin Limited Announcement VARROC Varroc Engineering Limited Financial Results MAHLOG Mahindra Logistics Limited Corporate Action MACPOWER Macpower CNC Machines Limited Financial Results AEQUS Aequs Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ALKEM files new disclosures

Track ALKEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ALKEM — Free

Free account · 2 AI queries/day